| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Fredric N Eshelman last filed a Form 4 in November 2021, as Director at HYPD. The filings on record cover 2 companies. Fredric N Eshelman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,299,750 shares of HYPD. Net of sales, the HYPD filings show accumulation of 335,000 shares.
Fredric N Eshelman has 9 Form 4 filings on record from March 2016 to November 2021, across 2 companies: Director at Hyperion Defi (HYPD), 2018–2021; Director at Bausch Health Companies (BHC), 2016–2017.
The 14 reported transactions were 7 stock awards, 4 option or other derivative awards, 2 tax withholdings and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $3.4M and no sales.
The only open-market purchase was 335,000 shares of HYPD at an average $10.00 on January 29, 2018, about $3.4M.
Shares as reported in the last Form 4 for each company; the most recent is from November 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2018 | HYPD Hyperion Defi, Inc. | Director, 10% Owner | Buy | 335,000 | $10.00 | $3,350,000.00 | +35.7% |